vs
Side-by-side financial comparison of ANAPTYSBIO, INC (ANAB) and RE/MAX Holdings, Inc. (RMAX). Click either name above to swap in a different company.
ANAPTYSBIO, INC is the larger business by last-quarter revenue ($108.2M vs $71.1M, roughly 1.5× RE/MAX Holdings, Inc.). ANAPTYSBIO, INC runs the higher net margin — 45.8% vs 2.0%, a 43.8% gap on every dollar of revenue. On growth, ANAPTYSBIO, INC posted the faster year-over-year revenue change (151.1% vs -1.8%). ANAPTYSBIO, INC produced more free cash flow last quarter ($98.0M vs $33.5M). Over the past eight quarters, ANAPTYSBIO, INC's revenue compounded faster (288.3% CAGR vs -4.7%).
AnaptysBio, Inc. is a clinical-stage biotechnology company focused on developing antibody-based immunotherapies for inflammatory diseases, immuno-oncology indications, and rare disease conditions. It primarily serves the U.S. market, advancing its innovative product candidate pipeline to address unmet medical needs via rigorous research and clinical development.
RE/MAX is an international real estate franchise operating in over 100 countries and territories that, in 2015, had over 100,000 agents in 6,800 offices.
ANAB vs RMAX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $108.2M | $71.1M |
| Net Profit | $49.6M | $1.4M |
| Gross Margin | — | — |
| Operating Margin | 61.8% | 13.1% |
| Net Margin | 45.8% | 2.0% |
| Revenue YoY | 151.1% | -1.8% |
| Net Profit YoY | 327.8% | -75.2% |
| EPS (diluted) | $1.64 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $108.2M | $71.1M | ||
| Q3 25 | $76.3M | $73.2M | ||
| Q2 25 | $22.3M | $72.8M | ||
| Q1 25 | $27.8M | $74.5M | ||
| Q4 24 | $43.1M | $72.5M | ||
| Q3 24 | $30.0M | $78.5M | ||
| Q2 24 | $11.0M | $78.5M | ||
| Q1 24 | $7.2M | $78.3M |
| Q4 25 | $49.6M | $1.4M | ||
| Q3 25 | $15.1M | $4.0M | ||
| Q2 25 | $-38.6M | $4.7M | ||
| Q1 25 | $-39.3M | $-2.0M | ||
| Q4 24 | $-21.8M | $5.8M | ||
| Q3 24 | $-32.9M | $966.0K | ||
| Q2 24 | $-46.7M | $3.7M | ||
| Q1 24 | $-43.9M | $-3.4M |
| Q4 25 | 61.8% | 13.1% | ||
| Q3 25 | 45.5% | 25.0% | ||
| Q2 25 | -117.5% | 19.3% | ||
| Q1 25 | -99.2% | 7.2% | ||
| Q4 24 | -22.4% | 5.9% | ||
| Q3 24 | -75.8% | 19.4% | ||
| Q2 24 | -367.5% | 20.6% | ||
| Q1 24 | -587.8% | 5.8% |
| Q4 25 | 45.8% | 2.0% | ||
| Q3 25 | 19.8% | 5.4% | ||
| Q2 25 | -173.5% | 6.4% | ||
| Q1 25 | -141.6% | -2.6% | ||
| Q4 24 | -50.5% | 8.0% | ||
| Q3 24 | -109.4% | 1.2% | ||
| Q2 24 | -425.3% | 4.7% | ||
| Q1 24 | -612.0% | -4.3% |
| Q4 25 | $1.64 | — | ||
| Q3 25 | $0.52 | — | ||
| Q2 25 | $-1.34 | — | ||
| Q1 25 | $-1.28 | — | ||
| Q4 24 | $-0.63 | — | ||
| Q3 24 | $-1.14 | — | ||
| Q2 24 | $-1.71 | — | ||
| Q1 24 | $-1.64 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $238.2M | $118.7M |
| Total DebtLower is stronger | — | $432.2M |
| Stockholders' EquityBook value | $37.2M | $452.4M |
| Total Assets | $364.4M | $582.5M |
| Debt / EquityLower = less leverage | — | 0.96× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $238.2M | $118.7M | ||
| Q3 25 | $109.8M | $107.5M | ||
| Q2 25 | $44.3M | $94.3M | ||
| Q1 25 | $98.6M | $89.1M | ||
| Q4 24 | $123.1M | $96.6M | ||
| Q3 24 | $191.6M | $83.8M | ||
| Q2 24 | $71.8M | $66.1M | ||
| Q1 24 | $53.7M | $82.1M |
| Q4 25 | — | $432.2M | ||
| Q3 25 | — | $433.3M | ||
| Q2 25 | — | $434.4M | ||
| Q1 25 | — | $435.3M | ||
| Q4 24 | — | $436.2M | ||
| Q3 24 | — | $437.2M | ||
| Q2 24 | — | $438.1M | ||
| Q1 24 | — | $439.0M |
| Q4 25 | $37.2M | $452.4M | ||
| Q3 25 | $-29.4M | $448.1M | ||
| Q2 25 | $-44.7M | $442.4M | ||
| Q1 25 | $34.0M | $433.5M | ||
| Q4 24 | $70.9M | $429.5M | ||
| Q3 24 | $84.4M | $423.1M | ||
| Q2 24 | $9.9M | $418.4M | ||
| Q1 24 | $47.8M | $412.0M |
| Q4 25 | $364.4M | $582.5M | ||
| Q3 25 | $353.1M | $582.2M | ||
| Q2 25 | $335.3M | $574.8M | ||
| Q1 25 | $422.1M | $571.4M | ||
| Q4 24 | $483.8M | $581.6M | ||
| Q3 24 | $493.4M | $578.6M | ||
| Q2 24 | $427.4M | $571.4M | ||
| Q1 24 | $405.8M | $566.7M |
| Q4 25 | — | 0.96× | ||
| Q3 25 | — | 0.97× | ||
| Q2 25 | — | 0.98× | ||
| Q1 25 | — | 1.00× | ||
| Q4 24 | — | 1.02× | ||
| Q3 24 | — | 1.03× | ||
| Q2 24 | — | 1.05× | ||
| Q1 24 | — | 1.07× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $98.0M | $40.9M |
| Free Cash FlowOCF − Capex | $98.0M | $33.5M |
| FCF MarginFCF / Revenue | 90.5% | 47.1% |
| Capex IntensityCapex / Revenue | 0.0% | 10.4% |
| Cash ConversionOCF / Net Profit | 1.98× | 28.39× |
| TTM Free Cash FlowTrailing 4 quarters | $19.6M | $56.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $98.0M | $40.9M | ||
| Q3 25 | $-27.4M | $17.7M | ||
| Q2 25 | $-40.2M | $4.6M | ||
| Q1 25 | $-10.7M | $5.7M | ||
| Q4 24 | $-66.7M | $59.7M | ||
| Q3 24 | $-10.1M | $17.6M | ||
| Q2 24 | $-21.3M | $15.9M | ||
| Q1 24 | $-37.3M | $9.4M |
| Q4 25 | $98.0M | $33.5M | ||
| Q3 25 | $-27.4M | $16.4M | ||
| Q2 25 | $-40.3M | $2.9M | ||
| Q1 25 | $-10.7M | $4.0M | ||
| Q4 24 | $-66.9M | $53.0M | ||
| Q3 24 | $-10.1M | $16.3M | ||
| Q2 24 | $-21.4M | $14.0M | ||
| Q1 24 | $-37.3M | $6.8M |
| Q4 25 | 90.5% | 47.1% | ||
| Q3 25 | -35.9% | 22.4% | ||
| Q2 25 | -180.9% | 4.0% | ||
| Q1 25 | -38.7% | 5.3% | ||
| Q4 24 | -155.3% | 73.2% | ||
| Q3 24 | -33.7% | 20.8% | ||
| Q2 24 | -194.6% | 17.8% | ||
| Q1 24 | -519.3% | 8.6% |
| Q4 25 | 0.0% | 10.4% | ||
| Q3 25 | 0.0% | 1.8% | ||
| Q2 25 | 0.2% | 2.2% | ||
| Q1 25 | 0.1% | 2.3% | ||
| Q4 24 | 0.6% | 9.1% | ||
| Q3 24 | 0.1% | 1.7% | ||
| Q2 24 | 0.3% | 2.4% | ||
| Q1 24 | 0.4% | 3.3% |
| Q4 25 | 1.98× | 28.39× | ||
| Q3 25 | -1.81× | 4.45× | ||
| Q2 25 | — | 0.97× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 10.28× | ||
| Q3 24 | — | 18.22× | ||
| Q2 24 | — | 4.29× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ANAB
Segment breakdown not available.
RMAX
| Franchising Segment | $50.1M | 70% |
| Broker Fees | $13.9M | 20% |
| Annual Dues | $7.4M | 10% |
